Market revenue in 2024 | USD 1,404.4 million |
Market revenue in 2030 | USD 2,500.4 million |
Growth rate | 10.2% (CAGR from 2025 to 2030) |
Largest segment | Dystonia |
Fastest growing segment | Epilepsy |
Historical data covered | 2018 - 2023 |
Base year for estimation | 2024 |
Forecast period covered | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pain Management, Epilepsy, Essential Tremor, Obsessive Compulsive Disorder (OCD), Parkinsons Disease, Depression, Dystonia |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Application | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
North America | 505.9 | 547.6 | 526.3 | 562.8 | 606.6 | 655.5 | 710.0 | 771.0 | 839.4 | 916.4 | 1,003.1 | 1,101.2 | 1,212.4 | 9.5% |
Europe | 197.5 | 216.3 | 210.4 | 227.6 | 248.3 | 271.4 | 297.5 | 326.9 | 360.2 | 397.9 | 440.8 | 489.7 | 545.6 | 10.8% |
Asia Pacific | 123.9 | 136.6 | 133.6 | 145.4 | 159.6 | 175.5 | 193.4 | 213.7 | 236.8 | 263.0 | 293.0 | 327.2 | 366.5 | 11.4% |
Latin America | 93.5 | 102.5 | 99.8 | 108.0 | 117.9 | 129.0 | 141.5 | 155.5 | 171.5 | 189.6 | 210.2 | 233.6 | 260.5 | 10.9% |
MEA | 40.5 | 44.5 | 43.4 | 47.1 | 51.5 | 56.4 | 62.0 | 68.3 | 75.5 | 83.6 | 92.8 | 103.4 | 115.5 | 11.1% |
Overall | 961.3 | 1,047.4 | 1,013.4 | 1,090.9 | 1,183.8 | 1,287.8 | 1,404.4 | 1,535.5 | 1,683.3 | 1,850.4 | 2,039.8 | 2,255.0 | 2,500.4 | 10.2% |
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account